Stock analysts at StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research report issued to clients and investors on Saturday. The firm set a “sell ...
Nalmefene, another newer agent, has a longer duration than naloxone, which can lead to prolonged and severe withdrawal symptoms. The American College of Medical Toxicology recommends against ...
31, 2025. Drug treatment advocates have urged Hochul to consider options to naloxone, such as nalmefene, a nasal spray produced by Indivior pharmaceuticals known as Opvee. In their letter to ...